These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31143458)

  • 1. Protecting essential information about genetic variants as trade secrets: a problem for public policy?
    Juergens AK; Francis LP
    J Law Biosci; 2018 Dec; 5(3):682-705. PubMed ID: 31143458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting Trade Secrets in Canada.
    Courage N; Calzavara J
    Cold Spring Harb Perspect Med; 2015 May; 5(9):a024489. PubMed ID: 25986591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The constitutional protection of trade secrets and patents under the Biologics Price Competition and Innovation Act of 2009.
    Epstein RA
    Food Drug Law J; 2011; 66(3):285-328. PubMed ID: 24505851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade secrets in life science and pharmaceutical companies.
    Nealey T; Daignault RM; Cai Y
    Cold Spring Harb Perspect Med; 2014 Nov; 5(4):. PubMed ID: 25414378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of plant varieties and parts as intellectual property.
    Williams SB
    Science; 1984 Jul; 225(4657):18-23. PubMed ID: 17775640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology as an intellectual property.
    Adler RG
    Science; 1984 Apr; 224(4647):357-63. PubMed ID: 6584975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal 3D printing: Patent law, trade secrets, and additive manufacturing.
    Rimmer M
    Front Res Metr Anal; 2022; 7():958761. PubMed ID: 36118015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-IP: staring down the Bayh-Dole Act with 2020 vision.
    Paradise J
    J Law Biosci; 2020; 7(1):lsaa073. PubMed ID: 33033619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constraints on gene patent protection fuel secrecy concerns: a qualitative study.
    Guerrini CJ; McGuire AL; Majumder MA; Bollinger JM; Rowan PJ
    J Law Biosci; 2017 Dec; 4(3):542-564. PubMed ID: 29868184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life forms protectable as subjects of US patents--microbes to animals (perhaps).
    Hodgins DS
    Appl Biochem Biotechnol; 1987; 16():79-93. PubMed ID: 3504131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life forms protectable as subjects of U.S. patents -- microbes to animals (perhaps).
    Hodgins DS
    Biomater Artif Cells Artif Organs; 1989; 17(2):205-24. PubMed ID: 2775879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act.
    Silva PJ; Ramos KS
    Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To Catch a Thief: Protecting Proprietary Information Including Trade Secrets From Corporate Espionage.
    Koen CM; London WB
    Health Care Manag (Frederick); 2019; 38(4):331-342. PubMed ID: 31663872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
    Crager SE; Guillen E; Price M
    Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent portfolios after myriad, how to fit in those new genes?
    Aceto JF
    ACS Med Chem Lett; 2013 Aug; 4(8):681-3. PubMed ID: 24900729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.